retatrutide type 2 diabetes trial results 2024 2025 💉 may be redefining obesity treatment. New data from TRIUMPH-1 showed: 🔥 ~28% average weight loss over 80 weeks 🔥 >30% weight loss in nearly half of participant #ObesityMedicine #Retatrutide #GLP1 #CardioMetabolic Retatrutide, a TRIPLE agonist (GLP1,

PV Paola Vargas 2026-01-16 I have try peptides Reta and its so I have try peptides Reta and its so good helping me with better habits and eating well I feel more energy and my progress its easier , very focus and the guiadance on usage its so good any questions they are there for you

This, and increased competition between pharma companies will enable millions of consumers to potentially access the first generation of drugs

Good Life Meds offers semaglutide to help people lose weight and manage diabetes

The largest Phase 2b trial (502 participants, 24 weeks) did not show statistically significant weight loss versus placebo